开尔新材 reported revenue of ¥0.10B for the period ended 2026-06-30, -13.0% year on year. Net income was ¥0.00B, a 0.8% net margin on a 21.7% gross margin. The largest revenue line is 工业保护搪瓷材料 at 47% of the total. Free cash flow for the period was ¥-0.02B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.10B | -13.0% |
| Gross profit | ¥0.02B | — |
| Operating income | ¥0.00B | — |
| Net income | ¥0.00B | -93.5% |
| Gross margin | 21.7% | Net margin 0.8% |
| Revenue Q/Q | +3.5% | — |
| Segment | Revenue | Share |
|---|---|---|
| 工业保护搪瓷材料 | ¥0.05B | 47.1% |
| 内立面装饰搪瓷材料 | ¥0.03B | 28.8% |
| 幕墙装饰工程 | ¥0.01B | 12.2% |
| 其他(补充) | ¥0.01B | 5.7% |
| 珐琅板绿色建筑幕墙材料 | ¥0.01B | 5.6% |
| 电力销售 | ¥0.00B | 0.7% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.08B | 78.3% |
| R&D | ¥0.00B | 4.7% |
| SG&A | ¥0.02B | 23.3% |
| Tax & other | ¥0.00B | 1.2% |
| Item | Amount |
|---|---|
| Total assets | ¥1.31B |
| Total liabilities | ¥0.19B |
| Shareholders' equity | ¥1.13B |
| Equity / assets | 85.8% |
| Operating cash flow | ¥-0.01B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥-0.02B |
| Cash conversion (OCF / net income) | 104% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
方直科技 ・ 上海新阳 ・ ST美晨 ・ 冠昊生物 ・ 东宝生物 ・ 飞力达 ・ 瑞丰光电 ・ 佳云科技 ・ 瑞丰高材 ・ 迪安诊断 ・ ST天玑 ・ 宝莱特
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies